Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Acta pharmacologica et toxicologica • 1974 | View Paper
“The transient striatal dopamine efflux induced by intrastriatal injection of dexamphetamine (1.0 microg/0.5 microl) was significantly reduced by systemic administration of reserpine (5mg/kg i.p.,”
Naunyn-Schmiedeberg's Archives of Pharmacology • 2004 | View Paper
“In contrast, comparably sized excitatory effects of d-amphetamine were blocked by α-methyl-p-tyrosine and greatly enhanced by pretreatment with reserpine.”
“SummaryThe ability of reserpine (0.1 mg/kg) to disrupt conditioned avoidance response (CAR) in cats could be completely reversed by (+)-amphetamine (2 mg/kg calculated as the bitartrate).”
“The ability of reserpine (0.1 mg/kg) to disrupt conditioned avoidance response (CAR) in cats could be completely reversed by (+)-amphetamine (2 mg/kg calculated as the bitartrate).”
Naunyn-Schmiedeberg's Archives of Pharmacology • 2004 | View Paper
“Where the latter prevent dexamphetamine-induced (3 mg/kg SC) reversion of akinesia in mice pretreated with reserpine (4 mg/kg SC, 5 h before test), tianeptine (20 mg/kg IP, 30 min before test) did not.”
Pharmacology Biochemistry and Behavior • 1999 | View Paper
“The attenuation of AMPH or MDMA-induced transmitter release by reserpine is thought to be counteracted by a reserpine-induced replenishment of stores.”